The Valley Desk

NCT04468984 · Interventional trial

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

Overall registry status Active not recruiting

Phase 3

Conditions Myelofibrosis (MF)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov